Swiss stocks - Factors to watch on Dec 14

ZURICH Dec 14 (Reuters) - Swiss stocks were set to open higher on Friday, following a rebound in Asian share markets.

The Swiss blue-chip index SMI .SSMI was indicated to rise 45 points to 6,428 points, premarket data provided by bank Clariden Leu showed .CLPRE.

The following are some of the main factors expected to affect Swiss stocks on Monday:

ROCHE (ROG.VX)

* The U.S. Food and Drug Administration is allowing enrolment to a phase III breast cancer study with Avastin that was temporary suspended on Sept. 25.

* Data showed Avastin plus commonly used chemotherapies improved progression-free survival in women previously treated with chemotherapy for advanced breast cancer in a late-stage trial.

* There are greater chances of cure for patients with HER2-positive early breast cancer when treated with one year of Herceptin, data presented at the weekend showed.

* A Phase II study showed trastuzumab-DM1 shrank tumours in women with highly advanced HER2-positive breast cancer.

* U.S. regulators said more supplies of flu drug Tamiflu were available.

For related news click on [ROG.VX]

PARTNERS GROUP (PGHN.S)

Asset manager Partners group says it will spin out its alternative beta strategies business, including insurance-linked securities.

For related news, click on (PGHN.S)

ADECCO (ADEN.VX)

The world's largest staffing group Adecco should have another challenging year in 2010 as the global economy recovers, its chief executive was quoted on Friday as saying.

For related news click on [ADEN.VX]

COMPANY STATEMENTS [CNR-CH]

* Rieter (RIEN.S) has agreed to sell its wholly owned French subsidiary Rieter Perfojet S.A.S, which generates sales of 40 million Swiss francs ($40 million), to Austrian-listed Andritz AG (ANDR.VI) for an undisclosed price

* Basilea (BSLN.S) says its Toctino drug has been recommended for regulatory approval in 15 additional European countries.

* Cicor Technologies (CICN.S) says expects to return to operating profit in 2010

* Evolva raises an additional 21 million francs ($21 million), completes merger with Aripida ARPN.S

* Logitech (LOGN.VX) Completes Acquisition of LifeSize Communications [LOGN.VX]

* Micronas (MASN.S) - Matthias Bopp is the new CEO of Micronas [MASN.S]

ECONOMY [M-CH]

Swiss producer and import price data for November are due at 0815 GMT.

EQUITY RESEARCH [CH-RCH]

FOR COMPANIES TRADING EX-DIVIDEND, PLEASE CLICK ON:

.EX.S for all Swiss stocks

.EXSMI.S for blue chips

.EXNSMI.S for other stocks